NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that revenues during the third quarter increased 13 percent year over year as the Human Health segment grew 24 percent.

The company reported revenues of $509.6 million for the three months ended Sept. 30, up from $452.9 million a year ago, surpassing the consensus Wall Street estimate of $505.5 million. Human Health revenues rose to $257.2 million, up from $206.6 million, while Environmental Health revenues grew 2 percent to $252.4 million from $246.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.